Henan Lingrui Pharmaceutical Co Ltd
SSE:600285

Watchlist Manager
Henan Lingrui Pharmaceutical Co Ltd Logo
Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
Watchlist
Price: 20.81 CNY -3.88% Market Closed
Market Cap: 11.6B CNY
Have any thoughts about
Henan Lingrui Pharmaceutical Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

15.1
Current
15.7
Median
13.3
Industry
Lower than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
15.1
=
Enterprise Value
10.9B CNY
/
EBITDA
720.7m CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
13
2-Years Forward
EV/EBITDA
11.1
3-Years Forward
EV/EBITDA
9.6

See Also

Discover More